The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
Open accessAbstract
Purpose: To evaluate the prognostic significance of CEBPA mutations in the context of established molecular markers in cytogenetically normal (CN) acute myeloid leukemia (AML) and gain biologic insights into leukemogenesis of the CN-AML molecular high-risk subset (FLT3 internal tandem duplication [ITD] positive and/or NPM1 wild type) that has a significantly higher incidence of CEBPA mutations than the molecular low-risk subset (FLT3-ITD negative and NPM1 mutated). Patients and Methods: One hundred seventy-five adults age less than 60 years with untreated primary CN-AML were screened before treatment for CEBPA, FLT3, MLL, WT1, and NPM1 mutations and BAALC and ERG expression levels. Gene and microRNA (miRNA) expression profiles were obtained for the CN-AML molecular high-risk patients. Results: CEBPA mutations predicted better event-free (P = .007), disease-free (P = .014), and overall survival (P < .001) independently of other molecular and clinical prognosticators. Among patients with CEBPA mutations, 91% were in the CN-AML molecular high-risk group. Within this group, CEBPA mutations predicted better event-free (P < .001), disease-free (P = .004), and overall survival (P = .009) independently of other molecular and clinical characteristics and were associated with unique gene and miRNA expression profiles. The major features of these profiles were upregulation of genes (eg, GATA1, ZFPM1, EPOR, and GFI1B) and miRNAs (ie, the miR-181 family) involved in erythroid differentiation and downregulation of homeobox genes. Conclusion: Pretreatment testing for CEBPA mutations identifies CN-AML patients with different outcomes, particularly in the molecular high-risk group, thus improving molecular risk-based classification of this large cytogenetic subset of AML. The gene and miRNA expression profiling provided insights into leukemogenesis of the CN-AML molecular high-risk group, indicating that CEBPA mutations are associated with partial erythroid differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Survival Analysis, Techniques for Censored and Truncated Data
Rao, M. B. (1998) · Technometrics · doi:10.1080/00401706.1998.10485206 · Cited by 3,617
MicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257 · cited 1×
“miR-181 family known to be involved in erythroid and lymphoid lineage differentiation.(39,40) In contrast, no hematopoietic function has”
BackgroundA MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,403
Self-citationCytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R., Pasqualucci, L., La Starza, R., Diverio, D., Colombo, E., Santucci, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041974 · Cited by 1,892
Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schäkel, U., Platzbecker, U., Wermke, M., Bornhäuser, M., Ritter, M., Neubauer, A., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4326 · Cited by 1,735
Byrd, J. C. (2002) · Blood · doi:10.1182/blood-2002-03-0772 · Cited by 1,597
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Yamamoto, Y. (2001) · Blood · doi:10.1182/blood.v97.8.2434 · Cited by 1,150
Pabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901
Fröhling, S., Schlenk, R. F., Breitruck, J., Benner, A., Kreitmeier, S., Tobis, K., Döhner, H., & Döhner, K. (2002) · Blood · doi:10.1182/blood-2002-05-1440 · Cited by 871
Döhner, K., Schlenk, R. F., Habdank, M., Scholl, C., Rücker, F. G., Corbacioglu, A., Bullinger, L., Fröhling, S., Döhner, H., & for the AML Study Group (AMLSG) (2005) · Blood · doi:10.1182/blood-2005-05-2164 · Cited by 849
Thiede, C., Koch, S., Creutzig, E., Steudel, C., Illmer, T., Schaich, M., Ehninger, G., & (DSIL), F. T. D. S. L. (2006) · Blood · doi:10.1182/blood-2005-08-3167 · Cited by 736
Schnittger, S., Schoch, C., Kern, W., Mecucci, C., Tschulik, C., Martelli, M. F., Haferlach, T., Hiddemann, W., & Falini, B. (2005) · Blood · doi:10.1182/blood-2005-06-2248 · Cited by 713
Whitman, S. P., Archer, K. J., Lin, F., Baldus, C. D., Becknell, B., Carlson, B. D., Carroll, A. J., Mrózek, K., Vardiman, J., George, S. L., et al. (2001) · PubMed · Cited by 633
Self-citationDisruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612
Mrózek, K., Marcucci, G., Paschka, P., Whitman, S. P., & Bloomfield, C. D. (2007) · Blood · doi:10.1182/blood-2006-06-001149 · Cited by 552
Self-citationPreudhomme, C., Sagot, C., Boissel, N., Cayuela, J.-M., Tigaud, I., de Botton, S., Thomas, X., Raffoux, E., Lamandin, C., Castaigne, S., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0990 · Cited by 501
Hox genes in hematopoiesis and leukemogenesis
Argiropoulos, B., & Humphries, R. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210760 · Cited by 492 · cited 1×
“These findings, along with upregulation of CD34 and CD38, support our hypothesis that the clonal cell population carrying CEBPA mutations is represented by a more mature type of malignant blasts.(50) These findings are also consistent with the significant association of CEBPA mutations with NPM1 wild-type status, whic…”
ResultNegative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
Zhang, P., Behre, G., Pan, J., Iwama, A., Wara-aswapati, N., Radomska, H. S., Auron, P. E., Tenen, D. G., & Sun, Z. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8705 · Cited by 459 · cited 1×
“Recent studies reported that SPI1 is a major downstream target of RUNX1(48) and that GATA1 blocks SPI1-mediated gene transactivation.(49) Therefore, it is possible that downregulation of RUNX1 and SPI1 and upregulation of X X X X X”
BackgroundFröhling, S., Schlenk, R. F., Stolze, I., Bihlmayr, J., Benner, A., Kreitmeier, S., Tobis, K., Döhner, H., & Döhner, K. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.060 · Cited by 458
MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia
Marcucci, G., Radmacher, M. D., Maharry, K., Mrózek, K., Ruppert, A. S., Paschka, P., Vukosavljevic, T., Whitman, S. P., Baldus, C. D., Langer, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074256 · Cited by 441
Self-citationMarcucci, G., Mrózek, K., Ruppert, A. S., Maharry, K., Kolitz, J. E., Moore, J. O., Mayer, R. J., Pettenati, M. J., Powell, B. L., Edwards, C. G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.15.610 · Cited by 381
Self-citationGombart, A. F., Hofmann, W.-K., Kawano, S., Takeuchi, S., Krug, U., Kwok, S. H., Larsen, R. J., Asou, H., Miller, C. W., Hoelzer, D., et al. (2002) · Blood · doi:10.1182/blood.v99.4.1332 · Cited by 293
C/EBPα mutations in acute myeloid leukaemias
Nerlov, C. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1363 · Cited by 280
Whitman, S. P., Ruppert, A. S., Radmacher, M. D., Mrózek, K., Paschka, P., Langer, C., Baldus, C. D., Wen, J., Racke, F., Powell, B. L., et al. (2008) · Blood · doi:10.1182/blood-2007-08-107946 · Cited by 266
Self-citationPU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang, G., Zhang, P., Hirai, H., Elf, S., Yan, X., Chen, Z., Koschmieder, S., Okuno, Y., Dayaram, T., Growney, J. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.7 · Cited by 259
Paschka, P., Marcucci, G., Ruppert, A. S., Whitman, S. P., Mrózek, K., Maharry, K., Langer, C., Baldus, C. D., Zhao, W., Powell, B. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2058 · Cited by 258
Self-citationBaldus, C. D., Tanner, S. M., Ruppert, A. S., Whitman, S. P., Archer, K. J., Marcucci, G., Caligiuri, M. A., Carroll, A. J., Vardiman, J. W., Powell, B. L., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0359 · Cited by 241
Self-citationMarcucci, G., Baldus, C. D., Ruppert, A. S., Radmacher, M. D., Mrózek, K., Whitman, S. P., Kolitz, J. E., Edwards, C. G., Vardiman, J. W., Powell, B. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6137 · Cited by 236
Self-citationRisk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
Bienz, M., Ludwig, M., Mueller, B. U., Oppliger Leibundgut, E., Ratschiller, D., Solenthaler, M., Fey, M. F., & Pabst, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1552 · Cited by 235
van Waalwijk van Doorn-Khosrovani, S. B., Erpelinck, C., Meijer, J., van Oosterhoud, S., van Putten, W. L. J., Valk, P. J. M., Berna Beverloo, H., Tenen, D. G., Löwenberg, B., & Delwel, R. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200216 · Cited by 235
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype
Boissel, N. (2005) · Blood · doi:10.1182/blood-2005-05-2174 · Cited by 224
Virappane, P., Gale, R., Hills, R., Kakkas, I., Summers, K., Stevens, J., Allen, C., Green, C., Quentmeier, H., Drexler, H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0333 · Cited by 218
Lin, L.-I., Chen, C.-Y., Lin, D.-T., Tsay, W., Tang, J.-L., Yeh, Y.-C., Shen, H.-L., Su, F.-H., Yao, M., Huang, S.-Y., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1816 · Cited by 214
MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis
Choong, M. L., Yang, H. H., & McNiece, I. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.12.002 · Cited by 210
GATA-1 Converts Lymphoid and Myelomonocytic Progenitors into the Megakaryocyte/Erythrocyte Lineages
Iwasaki, H., Mizuno, S.-I., Wells, R. A., Cantor, A. B., Watanabe, S., & Akashi, K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00242-5 · Cited by 200
Langer, C., Radmacher, M. D., Ruppert, A. S., Whitman, S. P., Paschka, P., Mrózek, K., Baldus, C. D., Vukosavljevic, T., Liu, C.-G., Ross, M. E., et al. (2008) · Blood · doi:10.1182/blood-2007-11-124958 · Cited by 192
Self-citationMarcucci, G., Maharry, K., Whitman, S. P., Vukosavljevic, T., Paschka, P., Langer, C., Mrózek, K., Baldus, C. D., Carroll, A. J., Powell, B. L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8720 · Cited by 192
Self-citationCaligiuri, M. A., Strout, M. P., Schichman, S. A., Mrózek, K., Arthur, D., Herzig, G. P., Baer, M., Schiffer, C. A., Heinonen, K., Knuutila, S., et al. (1996) · PubMed · Cited by 185
Self-citationBaldus, C. D., Thiede, C., Soucek, S., Bloomfield, C. D., Thiel, E., & Ehninger, G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6253 · Cited by 163
Self-citationInternal tandem duplications of the FLT3 gene are present in leukemia stem cells
Levis, M. J., Murphy, K. M., Pham, R., Kim, K.-T., Stine, A., Li, L., McNiece, I., Smith, B. D., & Small, D. (2005) · Blood · doi:10.1182/blood-2004-05-1902 · Cited by 161
Kolitz, J. E., George, S. L., Dodge, R. K., Hurd, D. D., Powell, B. L., Allen, S. L., Vélez-García, E., Moore, J. O., Shea, T. C., Hoke, E. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.106 · Cited by 150
Self-citationHeyworth, C. M., Pearson, S., May, G. E., & Enver, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf368 · Cited by 124
Radmacher, M. D. (2006) · Blood · doi:10.1182/blood-2006-02-005538 · Cited by 122
Self-citationWhitman, S. P., Ruppert, A. S., Marcucci, G., et al. (2007) · Blood · doi:10.1182/blood-2007-01-069831 · Cited by 107
Self-citationInduction of C/EBPα activity alters gene expression and differentiation of human CD34+ cells
Cammenga, J., Mulloy, J. C., Berguido, F. J., MacGrogan, D., Viale, A. J., & Nimer, S. D. (2003) · Blood · doi:10.1182/blood-2002-05-1546 · Cited by 98
Wagner, K., Zhang, P., Rosenbauer, F., Drescher, B., Kobayashi, S., Radomska, H. S., Kutok, J. L., Gilliland, D. G., Krauter, J., & Tenen, D. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508143103 · Cited by 66
Wouters, B. J., Louwers, I., Valk, P. J. M., Löwenberg, B., & Delwel, R. (2007) · Blood · doi:10.1182/blood-2006-08-042325 · Cited by 39
Regulatory Interaction of HNF1 to microRNA194 Gene During Intestinal Epithelial Cell Differentiation
Hino, K., Fukao, T., & Watanabe, M. (2007) · Nucleic Acids Symposium Series · doi:10.1093/nass/nrm208 · Cited by 35
Gene expression during terminal erythroid differentiation
Ney, P. A. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000231415.18333.2c · Cited by 35
Genetic Changes of CEBPA in Cancer: Mutations or Polymorphisms?
Resende, C., Regalo, G., Durães, C., Carneiro, F., & Machado, J. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7227 · Cited by 16
Cited by
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Self-citationStem cell gene expression programs influence clinical outcome in human leukemia
Eppert, K., Takenaka, K., Lechman, E. R., Waldron, L., Nilsson, B., van Galen, P., Metzeler, K. H., Poeppl, A., Ling, V., Beyene, J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2415 · Cited by 1,041
Marcucci, G., Maharry, K., Wu, Y.-Z., Radmacher, M. D., Mrózek, K., Margeson, D., Holland, K. B., Whitman, S. P., Becker, H., Schwind, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3730 · Cited by 763
Self-citationHaferlach, T., Kohlmann, A., Wieczorek, L., Basso, G., Kronnie, G. T., Béné, M.-C., De Vos, J., Hernández, J. M., Hofmann, W.-K., Mills, K. I., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4732 · Cited by 654
Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Marcucci, G., Haferlach, T., & Döhner, H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2554 · Cited by 570
Self-citation
Metadata
- Authors
- Marcucci, G., Maharry, K., Radmacher, M. D., Mrózek, K., Vukosavljevic, T., Paschka, P., Whitman, S. P., Langer, C., Baldus, C. D., Liu, C.-G., Ruppert, A. S., Powell, B. L., Carroll, A. J., Caligiuri, M. A., Kolitz, J. E., Larson, R. A., & Bloomfield, C. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-11-01
- Volume
- 26
- Issue
- 31
- Pages
- 5078-5087
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2007836133
- Cited by
- 302
- References
- 50
- FWCI
- 19.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.